SG11201601490XA - Risk markers for cardiovascular disease in patients with chronic kidney disease - Google Patents

Risk markers for cardiovascular disease in patients with chronic kidney disease

Info

Publication number
SG11201601490XA
SG11201601490XA SG11201601490XA SG11201601490XA SG11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA
Authority
SG
Singapore
Prior art keywords
patients
disease
chronic kidney
risk markers
cardiovascular disease
Prior art date
Application number
SG11201601490XA
Other languages
English (en)
Inventor
Eduardo Salas
Sara Pich
Manuel Arias
Roberto Elosua
Sergio Castillo
Original Assignee
Gendiag Exe Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49054458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201601490X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gendiag Exe Sl filed Critical Gendiag Exe Sl
Publication of SG11201601490XA publication Critical patent/SG11201601490XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201601490XA 2013-08-30 2014-08-29 Risk markers for cardiovascular disease in patients with chronic kidney disease SG11201601490XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13182484.9A EP2843056B8 (de) 2013-08-30 2013-08-30 Risikomarker für kardiovaskuläre Erkrankung bei Patienten mit chronischer Nierenerkrankung
PCT/EP2014/068387 WO2015028612A1 (en) 2013-08-30 2014-08-29 Risk markers for cardiovascular disease in patients with chronic kidney disease

Publications (1)

Publication Number Publication Date
SG11201601490XA true SG11201601490XA (en) 2016-03-30

Family

ID=49054458

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601490XA SG11201601490XA (en) 2013-08-30 2014-08-29 Risk markers for cardiovascular disease in patients with chronic kidney disease

Country Status (13)

Country Link
US (1) US20160215341A1 (de)
EP (2) EP2843056B8 (de)
JP (1) JP2016528907A (de)
AR (1) AR097489A1 (de)
AU (1) AU2014314097A1 (de)
CA (1) CA2922329A1 (de)
CL (1) CL2016000447A1 (de)
MX (1) MX2016002529A (de)
PE (1) PE20160603A1 (de)
RU (1) RU2656148C2 (de)
SG (1) SG11201601490XA (de)
UY (1) UY35719A (de)
WO (1) WO2015028612A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108172296A (zh) * 2018-01-23 2018-06-15 上海其明信息技术有限公司 一种数据库的建立方法和遗传疾病的风险预测方法
CN108897985A (zh) * 2018-05-04 2018-11-27 上海市内分泌代谢病研究所 一种糖化血红蛋白HbA1c遗传位点评分的方法及其应用
CN111354464B (zh) * 2018-12-24 2024-05-17 深圳先进技术研究院 Cad预测模型建立方法、装置以及电子设备
RU2709837C1 (ru) * 2019-03-29 2019-12-23 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ прогнозирования вероятности интраоперационных и ранних послеоперационных осложнений при органосохраняющих операциях при опухолях паренхимы почек
CN112034189B (zh) * 2020-06-16 2023-03-17 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 内皮素-1作为用于评价原发性慢性肾脏病患者无症状心血管器官损伤的标志物的应用
CN113643753B (zh) * 2021-05-26 2022-07-26 中国医学科学院阜外医院 冠心病多基因遗传风险评分及联合临床风险评估应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
WO2008060618A2 (en) * 2006-11-15 2008-05-22 University Of Florida Research Foundation Use of genetic determinants in cardiovascular risk assessment
US20090299645A1 (en) * 2008-03-19 2009-12-03 Brandon Colby Genetic analysis
PT2264183T (pt) * 2009-06-09 2017-03-14 Gendiag Exe Sl Marcadores de risco para doença cardiovascular
ES2387292B1 (es) * 2010-06-29 2013-10-30 Fundacio Institut De Recerca Hospital Universitari Vall D'hebron Combinacion de snps para determinar el riesgo de sufrir una enfermedad neurovascular
HUE029534T2 (hu) * 2011-08-05 2017-02-28 Gendiag Exe Sl Genetikai markerek kardiovaszkuláris betegség kockázatának becslésére
WO2013080227A1 (en) * 2011-11-28 2013-06-06 Decode Genetics Ehf Genetic variants useful for risk assessment of arterial disease

Also Published As

Publication number Publication date
MX2016002529A (es) 2016-06-21
EP2843056B1 (de) 2019-04-10
EP2843056A1 (de) 2015-03-04
PE20160603A1 (es) 2016-07-03
CA2922329A1 (en) 2015-03-05
RU2016111308A (ru) 2017-10-05
US20160215341A1 (en) 2016-07-28
AU2014314097A1 (en) 2016-03-24
EP3039156A1 (de) 2016-07-06
UY35719A (es) 2015-01-30
WO2015028612A1 (en) 2015-03-05
EP3039156B1 (de) 2019-01-02
AR097489A1 (es) 2016-03-16
RU2656148C2 (ru) 2018-05-31
JP2016528907A (ja) 2016-09-23
CL2016000447A1 (es) 2016-12-09
EP2843056B8 (de) 2019-06-26

Similar Documents

Publication Publication Date Title
EP2967371A4 (de) Vorrichtungen zur durchquerung einer chronischen totalen okklusion mit bildgebung
EP2967361A4 (de) Nierenpumpe
EP2967479A4 (de) Tomosynthesegesteuerte biopsie in bauchlage
EP3862044C0 (de) Hämodialysekatheter mit doppelter spitze
EP2985142A4 (de) Laminat
HK1222209A1 (zh) 隨時間檢測疾病中的突變
AU350549S (en) Breathalyzer
HK1223031A1 (zh) 用於降低慢性腎病患者的心力衰竭的枸櫞酸鐵
ZA201605051B (en) Multiprotease therapeutics for chronic pain
FI20130359L (fi) Tomosynteesikalibrointi mammografian yhteydessä
EP2967598A4 (de) Hydrodynamischer, exzentrisch schwenkbarer katheter
CL2016000447A1 (es) Marcadores de riesgo para cardiovasculopatías en pacientes con nefropatía crónica.
GB2510497B (en) Catheter
GB201322386D0 (en) Straight in line
GB201317621D0 (en) Kidney disease biomarker
GB2509783B (en) Foot tracking
EP2948769A4 (de) Blutplättchenbiomarker bei der krebsdiagnose
PL2875049T3 (pl) Sposoby zapobiegania i leczenia przewlekłej choroby nerek (ckd)
GB201305758D0 (en) Blood Pump
GB201305761D0 (en) Blood Pump
EP2989589A4 (de) Validierung in einem serialisierungsfluss
ZA201408618B (en) Disease resistance lociin onion
IL233698B (en) A catheter of multiple shapes
IL245189B (en) A system to improve fluid flow in a fluid body
PL3007772T3 (pl) Kompozycje do zastosowania w leczeniu dyslipidemii w przewlekłej chorobie nerek